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Background: Primary percutaneous coronary intervention (PCI) with the Proxis system (St. Jude Medical, St Paul, MN, USA) improves immediate 
microvascular flow post-procedure as measured by ST-segment resolution which could result in better outcomes. The aim of the study was to 
evaluate whether primary PCI with combined proximal embolic protection and thrombus aspiration results in smaller final infarct size (FIS) and 
improved left ventricular function (LVF) assessed by cardiovascular magnetic resonance (CMR) in ST-segment elevation myocardial infarction (STEMI) 
patients compared with primary PCI alone.
Methods: The ancillary CMR study included 206 STEMI patients who were enrolled in the PRoximal Embolic Protection in Acute myocardial 
infarction and Resolution of ST-Elevation (PREPARE) trial. CMR imaging was assessed between 4 and 6 months after index procedure.
Results: There were no significant differences in FIS (6.1g/m2 vs. 6.3 g/m2, p=0.78) and LVEF (50% vs. 50%, p=0.46) between both groups. Also, 
systolic wall thickening in infarct area (44% vs. 45%, p=0.93) or extent of transmural segments (8.3% of segments vs. 8.3% of segments, p=0.60) 
showed no significant differences. The incidence of major adverse cardiac and cerebral events (MACCE) at 6 months was similar in the Proxis and 
control group (8% vs. 10%, respectively, p=0.43).
Conclusion: Primary PCI with combined proximal embolic protection and thrombus aspiration in STEMI patients did not result in significant 
differences in FIS or LVF at follow-up CMR. In addition, there was no difference in the incidence of MACCE at 6 months.
